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Abstract
Objectives To investigate the effect of a change in sec-
ond-hand smoke (SHS) exposure on heart rate variability
(HRV) and pulse wave velocity (PWV), this study utilized
a quasi-experimental setting when a smoking ban was
introduced.
Methods HRV, a quantitative marker of autonomic
activity of the nervous system, and PWV, a marker of
arterial stiffness, were measured in 55 non-smoking hos-
pitality workers before and 3–12 months after a smoking
ban and compared to a control group that did not experi-
ence an exposure change. SHS exposure was determined
with a nicotine-specific badge and expressed as inhaled
cigarette equivalents per day (CE/d).
Results PWV and HRV parameters significantly changed
in a dose-dependent manner in the intervention group as
compared to the control group. A one CE/d decrease was
associated with a 2.3 % (95 % CI 0.2–4.4; p = 0.031)
higher root mean square of successive differences
(RMSSD), a 5.7 % (95 % CI 0.9–10.2; p = 0.02) higher
high-frequency component and a 0.72 % (95 % CI
0.40–1.05; p \ 0.001) lower PWV.
Conclusions PWV and HRV significantly improved after
introducing smoke-free workplaces indicating a decreased
cardiovascular risk.
Keywords Second-hand smoke  Smoke-free policy 
Arterial stiffness  Heart rate variability 
Hospitality workers  Passive smoking
Introduction
Several epidemiological studies from various countries
have shown the beneficial effects of a public indoor
smoking ban on cardiovascular health, especially acute
myocardial infarction (AMI). In Indiana, USA, hospital
admission rates for AMI declined by 50 % primarily
among non-smokers (Seo and Torabi 2007). In Helena,
Montana rates decreased by 40 %, but returned to former
levels after ban suspension (Sargent et al. 2004), while
decreased levels stayed low in Pueblo County after a longer
enforcement period (Bartecchi et al. 2006). Studies in
European cities suggest less pronounced decreases
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(Goodman et al. 2009). In Scotland, AMI rates decreased
by 17 % after the ban compared to a 4 % decrease in
England that did not have a ban (Pell et al. 2008). A recent
meta-analysis including 45 studies calculated significantly
lower hospital admission rates for both coronary events
(RR 0.848; 95 % CI 0.816–0.881) as well as for other heart
diseases (RR 0.610; 95 % CI 0.440–0.847) after introduc-
ing a comprehensive smoking ban (Tan and Glantz 2012).
However, most studies lack a control group as well as exact
information on smoking status and exposure because they
were conducted on a population level only. To assess the
mechanistic public health impact of public smoking bans,
population-based sensitive measures beyond AMI are
needed.
Heart rate variability (HRV) is a quantitative marker of
autonomic activity of the nervous system and lower HRV
is associated with higher cardiovascular morbidity and
mortality (Task Force of the European Society of Cardi-
ology 1996). The main influencing factors are sex, age,
physical activity, blood pressure and smoking status (Fel-
ber Dietrich et al. 2006). In a study by Pope et al. (2001),
acute exposure to SHS alternating with non-exposed peri-
ods led to consistently lower HRV measures during
exposure. A cross-sectional analysis showed that long-term
SHS-exposed persons for [2 h/day have higher high-fre-
quency (HF), lower total power (TP), low-frequency (LF)
and a lower LF/HF ratio than unexposed people (Felber
Dietrich et al. 2007). These are important frequency-
domain HRV measures providing further insight on fluc-
tuations of HR (Bilchick and Berger 2006). Chen et al.
(2008) showed that HRV was lower in mice during and
after exposure to second-hand smoke (SHS). No longitu-
dinal study on long-term SHS exposure and HRV has been
conducted so far.
Pulse wave velocity (PWV) provides a measure of
arterial stiffness (Vlachopoulos et al. 2010) which is an
important indicator of cardiovascular risk and atheroscle-
rosis (McEniery and Cockcroft 2007). In addition, arterial
stiffness is a powerful predictor of all-cause mortality
(Vlachopoulos et al. 2010, 2012). An increase of PWV was
observed after acute exposure to SHS (Barnoya and Glantz
2005) and after smoking one cigarette (Kubozono et al.
2011). Arteries such as the aorta and the femoral artery are
composed of different amounts of smooth muscle cell
layers and acute changes in arterial stiffness may reflect
changes in arterial tone due to autonomic innervation or
changes in endothelial function (Hill 2013).
In another study, PWV was found to be higher among
smokers than non-smokers, but smoking cessation did not
lead to any significant changes (Yu-Jie et al. 2013). A
prospective cohort study found a significant relationship
between the number of cigarettes smoked per day and the
annual rate of change in PWV (Tomiyama et al. 2010).
Long-term exposure to SHS and its impact on arterial
stiffness have not been examined as yet.
When Switzerland introduced a smoking ban in May
2010, the national law left room for exceptions (Ro¨o¨sli
and Rajkumar 2013). While several cantons—administra-
tive zones in Switzerland—completely banned smoking
venues and rooms, in other cantons either small smoking
venues or separated smoking rooms were still allowed.
This unique situation served as a quasi-experimental set-
ting for our prospective study. The aim was to directly
relate SHS exposure in non-smoking hospitality workers
before and after introduction of the smoking ban to HRV
and arterial stiffness. We further compared possible
changes in the intervention group which was subject to the
introduction of smoke-free workplaces to the control
group that did not experience any changes in SHS expo-
sure at the work place.
Methods
Study population
This is a quasi-experimental study comparing non-smoking
employees for whom second-hand smoke exposure at work
was eliminated as a result of the new smoking regulations
(intervention group) with non-smoking employees who did
not undergo any change in exposure (control groups). The
intervention group consisted of participants who had
worked for at least 1 year in venues where smoking was
either partially or completely allowed prior to the intro-
duction of the smoking ban (n = 55). After introduction of
the smoking ban, the intervention group was no longer
exposed to SHS at work. The control group consisted of
individuals who were exposed to SHS both before and after
the implementation of the smoking ban because of the
exceptional rules described above (n = 7) and non-smok-
ers who were regularly exposed to SHS at work or in
private without being employed in the hospitality sector
(n = 16). Due to difficulties in recruitment of non-smoking
hospitality workers, we additionally included a supple-
mentary group of 14 non-smoking hospitality workers at
baseline, who worked in a smoke-free environment at all
times (labeled supplementary group).
In the intervention group, a baseline examination was
conducted within the 3 months prior to the introduction of
the smoking ban. Subsequently, two follow-up examina-
tions were conducted at 3–6 months and 9–12 months after
the smoking ban introduction. The unexposed study par-
ticipants constituting the supplementary group were
examined once; all others were invited for examinations
three times. Intervals between examinations were also
about 6 months.
578 S. Rajkumar et al.
123
Recruitment procedure
A list of hospitality venues in the cantons of Zurich, Basel
City and Basel County was created using the digital Swiss
phonebook from 2009. Each venue received a letter that
was followed up by a phone call and a visit 2 weeks later.
Screening questionnaires were distributed to the waiting
staff, for providing information on the eligibility criteria
which were being between 18 and 65 years of age, working
at least half-time, having worked for at least 1 year in the
hospitality sector and having been a non-smoker for at least
5 years. Eligible study participants were invited to a health
examination, which was carried out in one of the two study
centers in Basel City and Zurich.
The non-hospitality workers were recruited by means of
an online advertisement looking for non-smokers who were
exposed to SHS on a regular basis, either privately or at
work.
Health examinations
The health examinations comprised cardiovascular and
respiratory tests as well as a computer-based interview.
About 20 min into the health examination, electrocardio-
grams (ECG) were continuously recorded for 10 min with
a 7-lead digital recorder (SEER Light, GE Healthcare,
Freiburg, Germany) with participants in the supine posi-
tion. ECGs were stored and subsequently analyzed on a PC
MARS workstation (GE Healthcare). Beat annotations
were automatically assigned by the GE software and
manually reviewed by an investigator blinded to the
exposure status of participants to ensure proper annotation
of non-sinus beats and artifacts. Only normal sinus beats
were used in the calculation of HRV metrics. The duration
between the R waves of consecutive normal sinus beats
(N–N intervals) was identified and only beats with an N–N
interval between 0.4 and 2.0 s and ratio between 0.8 and
1.2 were included in the analysis.
Calculations for time domain [standard deviation of N–N
intervals (SDNN); square root of the mean squared
differences of successive N–N intervals (RMSSD)] and fre-
quency-domain [low-frequency (LF) power (0.04–0.15 Hz),
high-frequency (HF) power (0.15–0.4 Hz), and their ratio
(LF/HF)] HRV parameters were evaluated on non-overlap-
ping 5-min intervals of ECG data using standard techniques
(Task Force of the European Society of Cardiology 1996).
Only 5-min intervals with a ratio of N–N/R–R intervals
[90 % were included in our analyses.
Subsequently, PWV and blood pressure were measured
using a VaSera VS-1500N device (Fukuda Denshi Co.,
Tokyo, Japan). Participants were in supine position and at
rest for at least 10 min beforehand. If the first two measures
were more than 0.5 m/s apart, a third measurement was
taken. For analysis, the average of the two more similar
measurements was used.
Exposure measurements
SHS was measured using newly developed MONIC pas-
sive sampling badges made of glass fiber. The amount of
nicotine on a badge was determined by gas chromatogra-
phy and used to calculate the number of passively smoked
cigarette equivalents (CEs) per day assuming a nicotine
content of 0.2 mg/cigarette and an average ventilation rate
of 10 L/min (Huynh et al. 2008; Durham et al. 2011).
In the hospitality venues that agreed to participate, at least
one MoNIC badge was placed for 1 week, often near the bar
where waiting personnel spend much of their working time.
We calculated for each hospitality worker a time-weighted
average workplace exposure (Rajkumar et al. 2013) by
multiplying their average workplace concentration by their
workload (in percentage of full time equivalent) and by 0.6,
which represents presence time at the work place including
holidays and considering the fact that nicotine levels
decrease when a venue is unattended (Rajkumar et al. 2013).
For non-hospitality workers average SHS exposure was
obtained from a personal badge that participants wore on
themselves at work and in private on a typical day.
Statistical analysis
Longitudinal analyses were conducted with two statistical
approaches. First, for the intervention group and the control
group a pre-/post-ban exposure variable was derived by
defining baseline data of both groups as pre-ban and the
two follow-up examinations as post-ban although in the
control group no ban was introduced. To increase statistical
power we did not differentiate between the follow-up
examinations and calculated an overall effect. For each
log-transformed outcome, a linear mixed effect model with
a random subject intercept was fit including a study group
by pre-/post-ban interaction term. HRV analyses were
adjusted for age, sex, BMI and season, PWV additionally
for time of day and systolic blood pressure as continuous
variables. Systolic blood pressure was adjusted for age,
sex, BMI, season and self-reported asthma. Finally, we
calculated crude and adjusted values of the health out-
comes prior and after the ban for both groups. Second,
covariate-adjusted exposure response associations were
calculated with a random intercept model using the esti-
mated work place SHS exposure at the time of each health
examination as explanatory variable using data from all
study participants, including the unexposed supplementary
group.
Data were analyzed using Stata 10.1 (StataCorp LP,
College Station, TX).
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Results
Exposure of the study population
Our study sample comprised 92 participants, 55 in the
intervention group, 23 in the control group and 14 in the
supplementary group. Groups did not differ in terms of
sociodemographic factors or health status, except for age,
self-reported asthma and physical activity (Table 1). There
were no diabetics in our sample. Average exposure in the
intervention group at baseline was 2.56 (95 % CI
1.70–3.44) cigarette equivalents per day (CE/day) and 0.16
(95 % CI 0.13–0.20) CE/day at follow-up resulting in an
exposure reduction of 2.40 CE/day (Table 1). In the
exposed control group exposure at baseline was 2.07 (95 %
CI 0.96–3.18) CE/day and 1.59 (95 % CI 0.67–2.50) CE/
day at follow-up.
Heart rate variability
From the HRV analyses 2 observations from the inter-
vention group and 5 from the control group were excluded
due to missing data (n = 1) or insufficient quality (n = 6).
At baseline, adjusted HRV parameters did not differ
between the intervention and the exposed control group
(Table 2). After the introduction of the smoking ban,
SDNN, RMSSD, HF, LF/HF and Total Power significantly
diverge between the two groups (Fig. 1). All these
parameters increase in the intervention group while
decreasing in the control group except the LF/HF ratio
which goes in the opposite direction, leading to a signifi-
cant change in the intervention group relative to the
exposed control group after implementation of the smoking
ban. The exposure–response model (Table 3) shows sig-
nificant increases of 2.3 % (95 % CI 0.2–4.4; p = 0.031)
and 5.7 % (95 % CI 0.9–10.2; p = 0.02) per decrease in
CE/day for RMSSD and HF, respectively. SDNN and Total
Power are associated with an increase of 1.8 % (95 % CI
-0.1 to 3.8; p = 0.069) and 4.1 % (95 % CI 0.0–8.0;
p = 0.051), while the LF/HF ratio significantly decreases
by -5.7 % (95 % CI -9.1 to -2.4); p = 0.001) per
decrease in CE/day. LF does not change materially. For
comparison, age-dependent changes in HRV parameters
obtained from the same model are shown in Table 3.
Pulse wave velocity
For the arterial stiffness analyses two participants had
missing data and technical problems resulted in the loss of
five observations for the PWV measurements (4 interven-
tion, 1 control). Table 2 shows crude and adjusted values
of PWV for the intervention and control group. Figure 2
illustrates the changes in adjusted values comparing the
intervention and control groups. Differences in PWV are
not significant although the intervention group shows a
steady decrease over the year, an effect not observed in the
control group. Systolic blood pressure decreases in the
intervention group and increases in the control group.
According to the exposure–response model (Table 3),
PWV declines with each CE/day decrease by 0.72 %
(95 % CI 0.40–1.05; p \ 0.001) whereas the decrease for
systolic blood pressure is not statistically significant.
Discussion
The smoking ban implementation led to statistically significant
improvements in HRV parameters in non-smoking hospitality
workers within 12 months. HRV increased in the intervention
group and PWV decreased as compared to the control group
that did not experience any changes in SHS exposure.
This study addresses several research gaps that the
Institute of Medicine 2010 report on SHS exposure and
cardiovascular effects identified (Secondhand Smoke
Exposure and Cardiovascular Effects: Making Sense of the
Evidence 2010). It directly examines the exposure–response
relationship of individual-level SHS exposure to HRV and
arterial stiffness and accounts for potential confounders,
including other risk factors for cardiovascular events. It also
compares possible changes in an intervention group where
smoke-free workplaces were introduced to a control group
that did not experience a change in SHS exposure.
Comparison with the literature
Our results on HRV are in line with the only other study
looking into long-term effects of SHS on HRV reporting
trends of lower levels in SDNN, Total Power and HF in
subjects that were exposed to SHS for[2 h/day compared
to unexposed subjects in a cross-sectional setting (Felber
Dietrich et al. 2007). Our findings are also supported by
other studies that looked at acute effects of SHS on HRV
and found consistent decreases in SDNN as soon as the
subjects were exposed (Pope et al. 2001) or right after
exposure (Zhang et al. 2013; Wilson et al. 2010). The
effect of active smoking on heart rate variability has been
studied extensively. While several studies found dimin-
ished HRV in heavy smokers (Barutcu et al. 2005; Levin
et al. 1992; Hayano et al. 1990), others did not confirm this
(Kageyama et al. 1997; Murata et al. 1992). A study
examining the effect of smoking cessation on HRV
recorded a significant increase 1 day after cessation in
heavy smokers, which although diminished, persisted
1 month after cessation (Yotsukura et al. 1998). This effect
is in line with another study looking at regular smokers
(Minami et al. 1999).
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Interpretation of our results
No significant difference in adjusted HRV parameters
between the intervention and the exposed control group
could be detected at baseline. SDNN, reflecting the overall
variability of HRV, increased by 1.8 % per decrease in CE/
day, which is more than the 1.5 % decrease of SDNN per
year of life according to the same exposure–response model.
Applying the average exposure reduction of 2.4 CEs/day
that we estimated in this study, this effect corresponds to a
delay of roughly 3 years in HRV reduction. RMSSD and HF
describing parasympathetic activity both increased signifi-
cantly. LF did not change measurably, while the LF/HF ratio
significantly decreased. These alterations support former
published evidence suggesting that passive smoking
increases the sympathetic drive and reduces parasympa-
thetic modulation as well as overall HRV (Dinas et al. 2013).
PWV was higher at baseline in the intervention group
than in the exposed control group. During the study, the
two groups drew closer together although the ban effect
was not significant. In the exposure–response model, PWV
significantly declined by 0.72 % per decrease in CE/day,
which corresponds to a ban effect of about 2.5 years of life.
The somewhat discordant result of the exposure–response
model as compared to the pre-/post-model means that
PWV was strongly correlated with SHS exposure at the
workplace, but changes within 1 year were small. This
pattern would be consistent with a more chronic effect of
SHS assuming that measured exposure at the workplace at
baseline is representative for chronic exposure.
Table 1 Study population, Switzerland 2010/2011
Intervention group
(n = 55)
Control group
(n = 23)
Supplementary group
(n = 14)
p value
Female sex 33 (60 %) 13 (57 %) 11 (79 %) 0.37
Age (years) 42.2 (95 % CI 39.0–45.4) 31.8 (95 % CI 26.4–37.2) 46.8 (95 % CI 41.1–52.5) 0.001
BMI (kg/m2) 26.0 (95 % CI 24.9–27.2) 25.0 (95 % CI 22.7–27.2) 25.0 (95 % CI 23.3–26.7) 0.23
Overweight (BMI [ 25) 28 (50.1 %) 11 (47.8 %) 5 (35.7 %) 0.60
Smoking status
Never-smokers 40 (72.7 %) 21 (91.3 %) 12 (85.7 %) 0.15
Ex-smokers 15 (27.3 %) 2 (8.7 %) 2 (14.3 %)
Self-reported asthma 4 (7.3 %) 8 (34.8 %) 1 (7.1) 0.01
Systolic blood pressure (mmHg) 125 (95 % CI 121–129) 122 (95 % CI 116–129) 129 (95 % CI 123–134) 0.16
Diastolic blood pressure (mmHg) 82 (95 % CI 79–84) 78 (95 % CI 73–82) 82 (95 % CI 78–87) 0.24
Hypertensiona 15 (27.3 %) 11 (4.4 %) 4 (28.6 %) 0.07
Self-reported diabetes mellitus 0 (0 %) 0 (0 %) 0 (0 %)
Coronary diseaseb 1 (1.8 %) 0 (0 %) 1 (7.1 %) 0.34
Betablocker intake 6 (10.9 %) 1 (4.4 %) 2 (14.3 %) 0.56
Allergicc 38 (69.1 %) 16 (69.6 %) 6 (42.9 %) 0.30
Self-reported physical activityd 19 (34.6 %) 16 (69.6 %) 10 (71.4 %) 0.02
Average workload (%) 93.8 (n = 55) 100.0 (n = 7) 84.3 (n = 14) 0.20
Type of workplace
Bar 5 (9.1 %) 2 (88.7 %) 0 (0 %) 0.007
Cafe 18 (32.7 %) 0 (0 %) 0 (0 %)
Restaurant 32 (58.2 %) 5 (21.7 %) 14 (100 %)
Other 0 (0 %) 16 (69.6 %) 0 (0 %)
Pre-ban workplace exposure
(cigarette equivalents/day)
2.56 (95 % CI 1.70–3.44) 2.07 (95 % CI 0.96–3.18) 0.12 (95 % CI 0.03–0.21)
Post-ban workplace exposure
(cigarette equivalents/day)
0.16 (95 % CI 0.13–0.20) 1.59 (95 % CI 0.67–2.50) NA
Values shown are arithmetic means at baseline except where indicated
 Kruskal–Wallis Test for numerical data, Chi square for proportion
a Defined as positive if diastolic blood pressure [90 mmHg or systolic blood pressure [140 mmHg
b Defined as: has taken medication for coronary heart disease during the past 7 days
c Reacted positively to at least one skin prick test
d Defined as: answered yes to: do you sweat at least once/week due to physical activity?
Workplace smoking bans 581
123
Strengths and limitations
To the best of our knowledge, this is the first study to
prospectively measure the effect of a smoking ban on
subclinical outcomes related to cardiovascular physiology.
A major asset of this study is the quasi-experimental setting
that allowed comparing the effects in workers where a
smoke-free workplace was introduced to a control group
without an exposure change. A further strength is that
exposure data were collected at the same time as the health
outcomes. A prospective study avoids the dangers of a
possible recall bias and mixed linear models allow for
within-subject clustering. Using the MoNIC badge, SHS
exposure was directly quantified by measuring nicotine
without using a surrogate measure such as airborne par-
ticulate matter.
Although exposure misclassification cannot be excluded,
in particular for individuals of the control group without a
workplace badge, the consistency of the results between the
pre-/post-model with the exposure–response model suggests
that exposure misclassification is unlikely to bias our results.
Due to limited sample size, we could not differentiate
between the two follow-up examinations in our analysis, but
this should not have caused any bias. Recruitment of eligible
participants was unexpectedly tedious as restaurant owners
were worried about financial losses caused by the smoking
ban, a concern that was shown to be baseless (Schulz et al.
2012). The exposed control group was younger, physically
Table 2 Heart rate variability and pulse wave velocity: pre-/post-model, Switzerland 2010/2011
Pre-ban Post-ban
Intervention group Control group p value# Intervention group Control group p value
n Geometric mean
(95 % CI)
n Geometric mean
(95 % CI)
n Geometric mean
(95 % CI)
n Geometric mean
(95 % CI)
SDNN (ms)a
Unadjusted 53 42.1 (37.8–47.0) 21 48.0 (37.5–61.5) 84 46.2 (42.3–50.4) 19 41.4 (33.4–51.3)
Adjusted 53 42.4 (38.2–47.1) 21 43.6 (37.0–51.4) 0.79 84 47.6 (43.3–52.2) 19 38.6 (32.3–46.2) 0.02
RMSSD (ms)a
Unadjusted 53 28.9 (24.9–33.5) 21 36.2 (25.8–50.8) 84 32.5 (28.8–36.7) 19 31.1 (22.2–43.6)
Adjusted 53 30.5 (26.7–34.8) 21 29.7 (24.1–36.7) 0.86 84 34.2 (30.2–38.6) 19 26.7 (21.2–33.4) 0.04
LF/HFa
Unadjusted 53 1.5 (1.2–1.9) 21 1.0 (0.6–1.6) 84 1.3 (1.1–1.5) 19 1.3 (0.8–2.0)
Adjusted 53 1.4 (1.1–1.7) 21 1.2 (0.9–1.7) 0.48 84 1.2 (1.0–1.5) 19 1.6 (1.2–2.3) 0.01
HF (ms2)a
Unadjusted 53 341 (241–484) 21 556 (265–1,166) 84 450 (343–592) 19 378 (179–796)
Adjusted 53 376 (280–505) 21 362 (226–582) 0.92 84 514 (390–677) 19 258 (155–430) 0.01
LF (ms2)a
Unadjusted 53 523 (409–668) 21 556 (337–918) 84 558 (462–675) 19 459 (287–733)
Adjusted 53 535 (424–674) 21 444 (310–636) 0.39 84 605 (494–741) 19 395 (266–588) 0.28
Total power (ms2)a
Unadjusted 53 1,797 (1,439–2,244) 21 2,348 (1,400–3,939) 84 2,189 (1,832–2,615) 19 1,739 (1,119–2,703)
Adjusted 53 1,807 (1,454–2,247) 21 1,951 (1,387–2,745) 0.73 84 2,323 (1,915–2,819) 19 1,517 (1,042–2,207) 0.02
PWV (m/s)b
Unadjusted 52 11.2 (10.8–11.6) 19 9.8 (8.9–10.8) 83 10.8 (10.5–11.1) 18 9.8 (9.2–10.5)
Adjusted 52 11.1 (10.8–11.4) 19 10.5 (10.1–11.0) 0.03 83 10.8 (10.5–11.1) 18 10.5 (10.0–11.0) 0.12
Systolic blood pressure (mmHg)c
Unadjusted 55 124.3 (120.7–127.9) 23 121.3 (114.7–128.4) 85 123.4 (120.5–126.4) 19 124.3 (119.8–128.9)
Adjusted 55 124.1 (120.7–127.5) 23 125.9 (120.4–131.4) 0.90 85 122.8 (119.5–126.1) 19 128.3 (122.3–134.3) 0.13
# Covariate-adjusted p value for the baseline difference according to the mixed linear model
 Covariate-adjusted p value for the intervention effect based on the interaction term of the mixed linear model
a Adjusted for age, sex, BMI and season
b Adjusted for age, sex, BMI, systolic blood pressure, circadian rhythm and season
c Adjusted for age, sex, BMI, season and asthma
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more active and reported more asthma. This might have
influenced the results. However, they are unlikely to explain
the full pattern, since we have considered these factors in the
exposure–response model. The pre-/post-model is mainly a
within-subject comparison where group differences are less
relevant.
Fig. 1 Covariate-adjusted heart rate variability parameters at baseline and follow-up, Switzerland 2010/2011. p values refer to the change in the
intervention group relative to the control group. SDNN standard deviation of NN intervals, RMSSD root mean square of successive difference
Table 3 Heart rate variability and pulse wave velocity: exposure–response model, Switzerland 2010/2011
Coefficienta (95 % CI) p value Age coefficientb (95 % CI) p value
SDNNc 1.8 (-0.1 to 3.8) 0.069 -1.5 (-2.1 to -0.9) \0.001
RMSSDc 2.3 (0.2 to 4.4) 0.031 -2.6 (-3.4 to -1.9) \0.001
LF/HFc -5.7 (-9.1 to -2.4) 0.001 3.2 (2.1 to 4.4) \0.001
HFc 5.7 (0.9 to 10.2) 0.020 -5.9 (-7.5 to -4.2) \0.001
LFc 0.6 (-4.1 to 5.1) 0.802 -2.9 (-4.2 to -1.7) \0.001
Total powerc 4.1 (0.0 to 8.0) 0.051 -3.0 (-4.1 to -1.8) \0.001
PWVd -0.72 (-0.40 to -1.05) \0.001 0.69 (0.54 to 0.85) \0.001
Systolic blood pressuree -0.07 (-0.32 to 0.47) 0.722 0.28 (0.13 to 0.43) \0.001
a Change in % per unit decrease in cigarette equivalents
b Change in % per 1 year increase in age
c Adjusted for age, sex, BMI and season
d Adjusted for age, sex, BMI, season, systolic blood pressure and circadian rhythm
e Adjusted for age, sex, BMI, season and asthma
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Conclusions
This study indicates that introduction of smoke-free
workplaces in hospitality venues substantially lowers car-
diovascular risk factors in non-smoking hospitality workers
and emphasizes the need for authorities worldwide to
implement comprehensive policies to prevent adverse
health effects.
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